Therapy News and Research

RSS

New silicon chips help identify patients with lupus

Researchers at the Stanford University School of Medicine and Intel Corp. have collaborated to synthesize and study a grid-like array of short pieces of a disease-associated protein on silicon chips normally used in computer microprocessors.

21 Aug 2012

Bile duct cancer chosen as next indication for PCI Biotech

PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that it has chosen bileduct cancer as the next indication for the use of its PCI (photochemical internalisation) localised cancer therapy. In this indication PCI Biotech’s proprietary photosensitiser Amphinex® will be used in combination with the generic cytotoxic agent gemcitabine. The aim is to start the clinical Proof of Concept study within end of 1H 2013.

21 Aug 2012

Kineta receives regulatory clearance to commence ShK-186 Phase I trial in autoimmune disease

Seattle-based biotech company Kineta, Inc. announced today it has received regulatory clearance in the Netherlands to initiate a first-in-human trial of ShK-186, an autoimmune drug candidate that specifically inhibits the Kv1.3 potassium ion channel.

21 Aug 2012

UCLA Medical Center receives platinum award for outstanding heart attack care

Ronald Reagan UCLA Medical Center has received an award for outstanding heart attack care from the American College of Cardiology Foundation called the NCDR ACTION Registry-GWTG Platinum Performance Achievement Award for 2012.

21 Aug 2012

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

Allergan, Inc. and Molecular Partners AG today announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.

21 Aug 2012

New tool reveals surprising clues about how cancer cells respond to therapy

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.

21 Aug 2012

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

The MitoTarget Project was a project funded by the European Commission, under their FP7 programme. It was funding for a call published in 2007.

21 Aug 2012

National Jewish Health, BWH to receive NHLBI grant for second phase of COPDGene project

The COPD Foundation (COPDF) recently announced that the National Heart, Lung, and Blood Institute (NHLBI) will fund the second phase (2012-2017) of the COPDGene project as R01 grants to National Jewish Health and the Brigham and Women's Hospital.

21 Aug 2012

Bonovo’s first PEEK lateral interbody fusion cage now available in China

Bonovo Orthopedics, Inc. announced today that it has launched the first PEEK lateral interbody fusion cage, Cross-Fuse in China.

21 Aug 2012

New attack on arthritis pain

A research team from the University of Melbourne is working on a new therapy that can potentially control the pain caused by diseases such as rheumatoid arthritis and osteoarthritis.

21 Aug 2012

Mayo Clinic receives approval for construction of new building on Phoenix campus

Mayo Clinic has been granted approval for construction of a 217,200 square-foot building on its Phoenix campus, a major expansion that will create a single-site, integrated Cancer Center. Mayo Clinic Cancer Center is the only National Cancer Institute-designated comprehensive cancer center with a multi-site, national presence, which allows us to serve a broad and diverse group of patients.

21 Aug 2012

Viewpoints: Insuring medical treatments are well researched; GOP Govs reluctance on exchanges may backfire

By 1990, many doctors were recommending hormone replacement therapy to healthy middle-aged women and P.S.A. screening for prostate cancer to older men. Both interventions had become standard medical practice. But in 2002, a randomized trial showed that preventive hormone replacement caused more problems (more heart disease and breast cancer) than it solved. ... Then, in 2009, trials showed that P.S.A. screening led to many unnecessary surgeries and had a dubious effect on prostate cancer deaths.

21 Aug 2012

Thiabendazole drug slows tumor growth and shows promise as chemotherapy for cancer

An inexpensive antifungal drug, thiabendazole, slows tumor growth and shows promise as a chemotherapy for cancer. Scientists in the College of Natural Sciences at The University of Texas at Austin made this discovery by exploiting the evolutionary relatedness of yeast, frogs, mice and humans.

21 Aug 2012

Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma

Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical trial to examine a two-month sustained release drug (OTX-TP2) for the treatment of ocular hypertension and glaucoma.

21 Aug 2012

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today successful results from two programs of work carried out by French partner VIVALIS (NYSE Euronext: VLS), confirming the ability of BioDiem’s Live Attenuated Influenza Virus (LAIV) to grow in VIVALIS’ proprietary EB66® cell line.

20 Aug 2012

Therapy News and Research

New silicon chips help identify patients with lupus

Bile duct cancer chosen as next indication for PCI Biotech

Kineta receives regulatory clearance to commence ShK-186 Phase I trial in autoimmune disease

UCLA Medical Center receives platinum award for outstanding heart attack care

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

New tool reveals surprising clues about how cancer cells respond to therapy

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

National Jewish Health, BWH to receive NHLBI grant for second phase of COPDGene project

Bonovo’s first PEEK lateral interbody fusion cage now available in China

New attack on arthritis pain

Mayo Clinic receives approval for construction of new building on Phoenix campus

Viewpoints: Insuring medical treatments are well researched; GOP Govs reluctance on exchanges may backfire

Thiabendazole drug slows tumor growth and shows promise as chemotherapy for cancer

Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

PD risk factors for potential clinical screening identified

HPV genotype may alter chemoradiotherapy outcome

Specialist referral unearths wide spectrum of adult primary immune deficiencies

Physiotherapy beneficial for Parkinson’s patients

Controversial activities of pro-anorexic bloggers may have benefits

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News